Study of the Influenza vaccine immune response using PMMA dialyzer.

Study of the Influenza vaccine immune response using PMMA dialyzer. - Influenza vaccine effectiveness in using PMMA dialyzer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019455

Enrollment

120

Registered

2015-10-26

Start date

2015-10-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease requiring hemodialysis

Interventions

Dialyzers will be chnaged to the PMMA dialyzers, on patients who was made immunity to influenza vaccination.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients whose age is over 20 years at the time of enrollment in this study.

Exclusion criteria

Exclusion criteria: A patient who is judged as the inadequate subject of this study by the doctor.

Design outcomes

Primary

Measure	Time frame
Improvement of immune responsiveness at 6 months after conversiton to PMMA dialyzer	—

Countries

Japan

Contacts

Public ContactTadashi Tomo

Oita university hospital Blood purfication center

tomo@oita-u.ac.jp097-586-6741

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026